About Castle Creek Biosciences
Castle Creek Biosciences is a company based in Exton (United States) founded in 2018. Castle Creek Biosciences has raised $192.8 million across 4 funding rounds from investors including Fidelity Investments, Paragon Biosciences and Horizon Tech Finance. The company has 41 employees as of December 31, 2022. Castle Creek Biosciences operates in a competitive market with competitors including Ironwood Pharma, Amryt Pharma, Castle Creek Pharma, VeraDermics and Lipum, among others.
- Headquarter Exton, United States
- Employees 41 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Castle Creek Biosciences, Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$192.8 M (USD)
in 4 rounds
-
Latest Funding Round
$112.8 M (USD), Series D
Jan 18, 2022
-
Investors
Fidelity Investments
& 3 more
-
Employee Count
41
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Castle Creek Biosciences
Unlock access to complete
Funding Insights of Castle Creek Biosciences
Castle Creek Biosciences has successfully raised a total of $192.8M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $112.8 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Castle Creek Biosciences
Castle Creek Biosciences has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Fidelity Investments, Paragon Biosciences and Horizon Tech Finance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm
|
Locked | Locked | Locked | |
|
Structured debt is provided to life sciences and technology firms.
|
Locked | Locked | Locked | |
|
Provider of brokerage accounts, retirement planning, wealth management, and trading platforms
|
Locked | Locked | Locked |
Investor details for Castle Creek Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Castle Creek Biosciences
Investment portfolio details for Castle Creek Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Castle Creek Biosciences
Detailed financials for Castle Creek Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Castle Creek Biosciences Comparisons
Peer comparison for Castle Creek Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Castle Creek Biosciences
Castle Creek Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ironwood Pharma, Amryt Pharma, Castle Creek Pharma, VeraDermics and Lipum, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for gastrointestinal disorders, including linaclotide, are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for rare dermatological and orphan diseases are developed.
|
|
| Locked | Locked | Locked |
Drugs for skin diseases, ENT disorders, and rare diseases such as urea cycle disorders
|
|
| Locked | Locked | Locked |
Drug-delivery platforms for pediatric wart treatments are developed.
|
|
| Locked | Locked | Locked |
Developer of antibody to treat juvenile idiopathic arthritis
|
|
| Locked | Locked | Locked |
Medicines for chronic diseases in children are developed and provided.
|
Detailed competitors of Castle Creek Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Castle Creek Biosciences
Complete news archive for Castle Creek Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Castle Creek Biosciences
Castle Creek Biosciences was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Castle Creek Biosciences is headquartered in Exton, United States. It is registered at Exton, Pennsylvania, United States.
Castle Creek Biosciences is a funded company, having raised a total of $192.8M across 4 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Castle Creek Biosciences is 41.
Castle Creek Biosciences was founded in 2018 and is headquartered in Exton, United States. A gene therapy platform based on autologous fibroblasts derived from patient skin cells is offered for rare skin and connective tissue disorders, including epidermolysis bullosa and localized scleroderma. Clinical development includes FCX-007 in phase 3 trials, with FCX-013 and CCP-020 in phase 2. Operations focus on dermatology and related rare disease areas.
Castle Creek Biosciences's top competitors include Ironwood Pharma, VeraDermics and Amryt Pharma.
Castle Creek Biosciences has 4 investors. Key investors include Fidelity Investments, Paragon Biosciences, Horizon Tech Finance, and Valor Equity Partners.